Compare iShares MSCI Indonesia ETF (EIDO) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Indonesia ETF vs Tilray Brands Inc — how do they compare? iShares MSCI Indonesia ETF trades at $12.68, while Tilray Brands Inc trades at $4.71 (market cap $649.42M). The key difference: iShares MSCI Indonesia ETF is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.
| EIDO | TLRY | |
|---|---|---|
52-Week High | $19.22 | $21.00 |
52-Week Low | $10.80 | $3.88 |
Market Cap | — | $649.42M |
Sector | — | Health |
Enterprise Value | — | $816.55M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EIDO trades at $12.64, down 0.86% on the day, with a bearish technical signal from moving averages and mixed oscillators. The stock faces headwinds from foreign capital outflows in Asian equities and Indonesia's economic exposure. A dividend of $0.23 is scheduled for payment in June 2026, offering income potential amid weak price action.
The outlook remains cautious due to technical downtrends and macroeconomic pressures on Indonesian assets. Investment appeal hinges on valuation discounts and potential policy support, but risks include currency volatility and limited earnings growth. Investors require patience for a turnaround.
TLRY trades at $4.71, up 6.56% today, with a bullish technical signal from moving averages but mixed oscillators. Revenue grew to $821M in 2025, yet the company posted a net loss of -$2.19B, reflecting profitability challenges. Recent news highlights growth initiatives, including a partnership with Wolverhampton Wanderers and a new THC pouch launch. The stock remains volatile, with a low P/S of 0.58 and P/B of 0.4, suggesting potential undervaluation amid ongoing losses.
Outlook is cautious; TLRY's path to profitability hinges on revenue growth and cost management. Risks include persistent losses, high debt, and regulatory uncertainty. Analyst consensus is mixed, with 25% buy ratings but 65% hold, indicating skepticism. Investors should weigh growth potential against financial instability and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares MSCI Indonesia ETF
The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index is a free float-adjusted market capitalization-weighted index that is designed to measure the performance of the large-, mid- and small-capitalization segments of the equity market in Indonesia. The fund is non-diversified.
Read more on EIDO →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
